Literature DB >> 21277198

II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.

Yuefei Shao1, Gopinadhan N Anilkumar, Carolyn Diianni Carroll, Guizhen Dong, James W Hall, Doug W Hobbs, Yueheng Jiang, Chung-Her Jenh, Seong Heon Kim, Joseph A Kozlowski, Brian F McGuinness, Stuart B Rosenblum, Inna Schulman, Neng-Yang Shih, Youheng Shu, Michael K C Wong, Wensheng Yu, Lisa Guise Zawacki, Qingbei Zeng.   

Abstract

The structure-human CXCR3 binding affinity relationship of a series of pyridyl-piperazinyl-piperidine derivatives was explored. The optimization campaign highlighted the pronounced effect of 2'-piperazine substitution on CXCR3 receptor affinity. Analog 18j, harboring a 2'(S)-ethylpiperazine moiety, exhibited a human CXCR3 IC(50) of 0.2 nM.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21277198     DOI: 10.1016/j.bmcl.2010.12.114

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Metabolic profiling of ligands for the chemokine receptor CXCR3 by liquid chromatography-mass spectrometry coupled to bioaffinity assessment.

Authors:  Marija Mladic; Danny J Scholten; Maikel Wijtmans; David Falck; Rob Leurs; Wilfried M A Niessen; Martine J Smit; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2015-07-12       Impact factor: 4.142

2.  Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.